IRIS Accounts Production v23.2.0.158 OC337424 designated member designated member 6.4.22 5.4.23 5.4.23 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhOC3374242022-04-05OC3374242023-04-05OC3374242022-04-062023-04-05OC3374242021-04-05OC3374242021-04-062022-04-05OC3374242022-04-05OC337424ns10:Originalns15:EnglandWales2022-04-062023-04-05OC337424ns14:PoundSterlingns10:Original2022-04-062023-04-05OC337424ns10:Originalns10:Director12022-04-062023-04-05OC337424ns10:Original2022-04-062023-04-05OC337424ns10:Originalns10:Director22022-04-062023-04-05OC337424ns10:Original2023-04-05OC337424ns10:Originalns10:LimitedLiabilityPartnershipLLP2022-04-062023-04-05OC337424ns10:Originalns10:SmallEntities2022-04-062023-04-05OC337424ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-062023-04-05OC337424ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-062023-04-05OC337424ns10:LimitedLiabilityPartnershipsSORPns10:Original2022-04-062023-04-05OC337424ns10:Originalns10:FullAccounts2022-04-062023-04-05OC337424ns10:Originalns10:Director42022-04-062023-04-05OC337424ns10:Originalns10:Director52022-04-062023-04-05OC337424ns10:Originalns10:Director62022-04-062023-04-05OC337424ns10:Originalns10:Director32022-04-062023-04-05OC337424ns10:Director8ns10:Original2022-04-062023-04-05OC337424ns10:Originalns10:Director92022-04-062023-04-05OC337424ns10:Director10ns10:Original2022-04-062023-04-05OC337424ns10:Originalns10:Director112022-04-062023-04-05OC337424ns10:Originalns10:Director122022-04-062023-04-05OC337424ns10:Originalns10:RegisteredOffice2022-04-062023-04-05OC337424ns10:Original2022-04-05OC337424ns10:Originalns5:CurrentFinancialInstruments2023-04-05OC337424ns10:Originalns5:CurrentFinancialInstruments2022-04-05OC337424ns10:Originalns5:PlantMachinery2022-04-062023-04-05OC337424ns10:Original2021-04-062022-04-05OC337424ns10:Originalns5:PlantMachinery2022-04-05OC337424ns10:Originalns5:PlantMachinery2023-04-05OC337424ns10:Originalns5:PlantMachinery2022-04-05OC337424ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-04-05OC337424ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-04-05
REGISTERED NUMBER: OC337424 (England and Wales)















Unaudited Financial Statements

for the Year Ended 5 April 2023

for

Cambridge Urology Partnership LLP

Cambridge Urology Partnership LLP (Registered number: OC337424)






Contents of the Financial Statements
for the Year Ended 5 April 2023




Page

General Information 1

Balance Sheet 2

Notes to the Financial Statements 5


Cambridge Urology Partnership LLP

General Information
for the Year Ended 5 April 2023







DESIGNATED MEMBERS: J D G F Kelly
Tev Aho Ltd
Nimish Shah Ltd
Oliver Wiseman Ltd
C Kastner Medical Ltd
Russell Oncology Ltd
J N & Z Armitage Ltd
Dr R J Benson Limited
Aylesford Medical Consulting Ltd
Hills Medical Ltd
Lamb Urology Consultants Limited





REGISTERED OFFICE: Nuffield Health
Cambridge Hospital
Trumpington Road
Cambridge
Cambridgeshire
CB2 8AF





REGISTERED NUMBER: OC337424 (England and Wales)





ACCOUNTANTS: Stanbridge Associates Limited
7 Lindum Terrace
Lincoln
Lincolnshire
LN2 5RP

Cambridge Urology Partnership LLP (Registered number: OC337424)

Balance Sheet
5 April 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 76,370 43,088

CURRENT ASSETS
Debtors 5 213,204 171,708
Cash at bank 174,789 135,382
387,993 307,090
CREDITORS
Amounts falling due within one year 6 8,249 6,250
NET CURRENT ASSETS 379,744 300,840
TOTAL ASSETS LESS CURRENT LIABILITIES
and
NET ASSETS ATTRIBUTABLE
TO MEMBERS

456,114

343,928

Cambridge Urology Partnership LLP (Registered number: OC337424)

Balance Sheet - continued
5 April 2023

2023 2022
Notes £    £    £    £   
LOANS AND OTHER DEBTS
DUE TO MEMBERS

7

456,114

343,928

TOTAL MEMBERS' INTERESTS
Loans and other debts due to
members

7

456,114

343,928
Amounts due from members 5 (62,268 ) (54,515 )
393,846 289,413

The LLP is entitled to exemption from audit under Section 477 of the Companies Act 2006 as applied to LLPs by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008 for the year ended 5 April 2023.

The members acknowledge their responsibilities for:
(a)ensuring that the LLP keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 as applied to LLPs by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the LLP as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 as applied to LLPs by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008 relating to financial statements, so far as applicable to the LLP.

Cambridge Urology Partnership LLP (Registered number: OC337424)

Balance Sheet - continued
5 April 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to LLPs subject to the small LLPs regime.

In accordance with Section 444 of the Companies Act 2006 as applied to LLPs by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008, the Income Statement has not been delivered.

The financial statements were approved by the members of the LLP and authorised for issue on 13 November 2023 and were signed by:




Aylesford Medical Consulting Ltd - Designated member




Dr R J Benson Limited - Designated member


Cambridge Urology Partnership LLP (Registered number: OC337424)

Notes to the Financial Statements
for the Year Ended 5 April 2023

1. STATUTORY INFORMATION

Cambridge Urology Partnership LLP is registered in England and Wales. The LLP's registered number and registered office address can be found on the General Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the requirements of the Statement of Recommended Practice, Accounting by Limited Liability Partnerships. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% Reducing Balance

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The LLP operates a defined contribution pension scheme. Contributions payable to the LLP's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEE INFORMATION

The average number of employees during the year was NIL (2022 - 2 ).

Cambridge Urology Partnership LLP (Registered number: OC337424)

Notes to the Financial Statements - continued
for the Year Ended 5 April 2023

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 6 April 2022 143,154
Additions 33,282
Disposals (30,000 )
At 5 April 2023 146,436
DEPRECIATION
At 6 April 2022 100,066
Eliminated on disposal (30,000 )
At 5 April 2023 70,066
NET BOOK VALUE
At 5 April 2023 76,370
At 5 April 2022 43,088

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE
YEAR
2023 2022
£    £   
Trade debtors 150,936 117,193
Other debtors 62,268 54,515
213,204 171,708

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE
YEAR
2023 2022
£    £   
Trade creditors 1,490 -
Other creditors 6,759 6,250
8,249 6,250

Cambridge Urology Partnership LLP (Registered number: OC337424)

Notes to the Financial Statements - continued
for the Year Ended 5 April 2023

7. LOANS AND OTHER DEBTS DUE TO MEMBERS

In the event of winding up or closure other creditors would take precedence over loans and other debts due to members for payment.

8. RELATED PARTY DISCLOSURES

CUP LLP pay an annual amount of £20,000 as a management fee to Aylesford Medical Consulting Ltd.